| Basics |
Array Technologies, Inc.
Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
|
| IPO Date: |
October 15, 2020 |
| Sector: |
Technology |
| Industry: |
Solar |
| Market Cap: |
$1.13B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.53 | 3.24%
|
| Avg Daily Range (30 D): |
$0.24 | 3.41%
|
| Avg Daily Range (90 D): |
$0.22 | 3.67%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
4.28M |
| Avg Daily Volume (30 D): |
7.85M |
| Avg Daily Volume (90 D): |
6.15M |
| Trade Size |
| Avg Trade Size (Sh.): |
121 |
| Avg Trade Size (Sh.) (30 D): |
179 |
| Avg Trade Size (Sh.) (90 D): |
161 |
| Institutional Trades |
| Total Inst.Trades: |
5,650 |
| Avg Inst. Trade: |
$2.26M |
| Avg Inst. Trade (30 D): |
$1.98M |
| Avg Inst. Trade (90 D): |
$2.08M |
| Avg Inst. Trade Volume: |
.15M |
| Avg Inst. Trades (Per Day): |
4 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.06M |
| Avg Closing Trade (30 D): |
$5.3M |
| Avg Closing Trade (90 D): |
$3.79M |
| Avg Closing Volume: |
349.37K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q3 2024 |
|
Basic EPS
|
|
$.02
|
$-1.02
|
|
Diluted EPS
|
|
$.02
|
$-1.02
|
|
Revenue
|
$
|
$ 302.36M
|
$ 231.41M
|
|
Gross Profit
|
$
|
$ 76.43M
|
$ 78.32M
|
|
Net Income / Loss
|
$
|
$ 16.75M
|
$ -141.35M
|
|
Operating Income / Loss
|
$
|
$ 27.28M
|
$ -132.68M
|
|
Cost of Revenue
|
$
|
$ 225.94M
|
$ 153.09M
|
|
Net Cash Flow
|
$
|
$ -14.65M
|
$ 50.05M
|
|
PE Ratio
|
|
|
|
|
|
|
